OneroRX Announces Appointment of Two New Board Members

FOR IMMEDIATE RELEASE 

May 19, 2026 — OneroRX today announced the appointment of Dr. Rinku Patel and Daniel Varnum to its Board of Directors, as it continues to expand its impact in healthcare innovation and pharmacy solutions. 

Dr. Patel brings extensive leadership experience in healthcare strategy, operations, and growth initiatives. Her expertise will support OneroRx’s continued focus on delivering patient-centered pharmacy services and scalable healthcare solutions.

Mr. Varnum joins the board with a strong background in business leadership, strategic development, and operational excellence. His perspective and industry experience will help guide OneroRx through its next phase of growth and innovation. 

“We are excited to welcome Dr. Patel and Mr. Varnum to the OneroRx Board of Directors,” Joseph Dunham, Chairman of the Board & Chief Executive Officer of OneroRx said. “Their combined experience, strategic insight, and leadership will be invaluable as we continue advancing our mission to improve patient outcomes and transform the pharmacy experience.” 

The appointments reflect OneroRx’s commitment to building a diverse and experienced Board of Directors capable of supporting long-term growth, innovation, and operational excellence. Dr. Patel and Mr. Varnum will join the existing Board of Directors including Joseph Dunham, Greg Johansen, Shelley L. Boyce, Beth Haas, and Paul Juffer.  

About OneroRX 

For OneroRx, corporate social responsibility is at the core of our mission: We provide integrated pharmacy services to promote patient health and wellness in underserved communities. We are committed to transforming the pharmacy experience by putting people first, providing compassionate care, personalized solutions to improve health outcomes and empower customers.